Categories: Market Research

Cardiac Pacemakers Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope
A cardiac pacemaker refers to a small electronic device that generates electrical impulses and prevents the heart from beating too fast or slow and helps in treating heart conditions such as arrhythmias is a heart condition where the heart beats irregularly. The cardiac pacemakers are used to maintain the rhythm of heartbeats.

Sizing and Forecast
The cardiac pacemakers market size has grown strongly in recent years. It will grow from $4.58 billion in 2023 to $4.86 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to aging population and the prevalence of cardiovascular diseases, growing awareness of arrhythmias and the need for treatment, investment in research and development for pacemaker innovation, evolving healthcare infrastructure and access to medical devices, and regulatory approvals for novel pacemaker features and technologies..

The cardiac pacemakers market size is expected to see strong growth in the next few years. It will grow to $6.14 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to focus on lead durability and reduction of complications, remote programming and telehealth services for pacemaker patients, expansion of emerging markets and rising healthcare expenditure, enhanced battery technologies for longer pacemaker lifespans, and regulatory support for expedited pacemaker approvals.. Major trends in the forecast period include electrophysiology advancements for precision implantation, integration of pacemaker data into electronic health records (ehrs), integration of artificial intelligence (ai) for predictive pacemaker maintenance, advancements in pacemaker technology, including miniaturization, and telemedicine and remote monitoring.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

Segmentation & Regional Insights
The cardiac pacemakers market covered in this report is segmented –

1) By Type: Implantable, External
2) By Technology: Biventricular, Single Chambered, Dual Chambered
3) By Application: Arrhythmias, Heart Blockage, Atrial Fibrillation, Long QT Syndrome, Congestive Cardiac Failure, Other Applications
4) By End User: Clinics And Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers

North America was the largest region in the cardiac pacemakers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac pacemakers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7507&type=smp

Major Driver Impacting Market Growth
An increase in cardiovascular diseases is significantly contributing to the growth of the cardiac pacemaker market. Cardiovascular disease (CVD) refers to disorders that affect the heart or blood vessels. These include arrhythmias, aorta disease, congenital heart disease, heart attack, and others. Cardiac pacemakers are electric activity-generating devices that are used to treat patients suffering from cardiovascular diseases. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. . Therefore, the rising incidence of cardiovascular diseases will drive the growth of the cardiac pacemaker market.

Key Industry Players
Major companies operating in the cardiac pacemakers market include Medtronic plc, Lepu Medical Technology Co., Abbott Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, Oscor Inc., Osypca Medical GmbH, Zoll Medical Corporation, MicroPort Scientific Corporation, Cook Group Incorporated, Sorin Group, Vitatron & Medical Co., Cordis Inc., Shree Pacetronix Limited, Medico SpA, St. Jude Medical, LivaNova PLC, Schiller AG, BTL Industries Inc., CCC Medical Devices, Cardiostim, Advena Ltd., Mediana Co. Ltd., Vimecon GmbH, Cardiac Science Corporation, Greatbatch Medical, Galix Biomedical Instrumentation, Nanjing MicroPort Medical, A&E Medical Corporation, Cardionovum GmbH

The cardiac pacemakers market report table of contents includes:

1. Executive Summary

2. Cardiac Pacemakers Market Characteristics

3. Cardiac Pacemakers Market Trends And Strategies

4. Cardiac Pacemakers Market – Macro Economic Scenario

5. Global Cardiac Pacemakers Market Size and Growth

.
.
.

31. Global Cardiac Pacemakers Market Competitive Benchmarking

32. Global Cardiac Pacemakers Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Cardiac Pacemakers Market

34. Cardiac Pacemakers Market Future Outlook and Potential Analysis

35. Appendix